Illumina, Inc. (NASDAQ: ILMN), and Ovation.io, Inc., an organization dedicated to building best-in-class multiomics datasets, today announced the development of the largest commercially available ...

The research, led by renowned obesity researcher and Phenomix co-founder, Andres Acosta, MD, PhD, and presented by Thomas ...

Keeping up with the GLP-1 area is a full-time job by itself. First off, you have the recent development that these drugs are ...

Following on from a remarkable study in mice, scientists have now confirmed that silencing a certain protein in muscle tissue ...

A study from Jiangnan University reveals that a gut microbe, Bacteroides vulgatus, can naturally regulate blood sugar levels ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.

Dataset will advance development of GLP-1 therapies in new indications and accelerate discovery of novel drug targets in patients who are unresponsive to therapies "The power of whole-genome and ...